Related Experiment Video
Updated: Oct 1, 2026

Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice
Published on: September 17, 2015
alpha-Adrenergic response and myofilament activity in mouse hearts lacking PKC phosphorylation sites on cardiac TnI
David E Montgomery1, Beata M Wolska, W Glen Pyle
1Program in Cardiovascular Sciences, Department of Physiology and Biophysics, Section of Cardiology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
Abstract:
Protein kinase C (PKC)-mediated phosphorylation of cardiac myofilament (MF) proteins has been shown to depress the actomyosin interaction and may be important during heart failure. Biochemical studies indicate that phosphorylation of Ser(43) and Ser(45) of cardiac troponin I (cTnI) plays a substantial role in the PKC-mediated depression. We studied intact and detergent-extracted papillary muscles from nontransgenic (NTG) and transgenic (TG) mouse hearts that express a mutant cTnI (Ser43Ala, Ser45Ala) that lacks specific PKC-dependent phosphorylation sites. Treatment of NTG papillary muscles with phenylephrine (PE) resulted in a transient increase and a subsequent 62% reduction in peak twitch force. TG muscles showed no transient increase and only a 45% reduction in force. There was a similar difference in maximum tension between NTG and TG fiber bundles that had been treated with a phorbol ester and had received subsequent detergent extraction. Although levels of cTnI phosphorylation correlated with these differences, the TG fibers also demonstrated a decrease in phosphorylation of cardiac troponin T. The PKC-specific inhibitor chelerythrine inhibited these responses. Our data provide evidence that specific PKC-mediated phosphorylation of Ser(43) and Ser(45) of cTnI plays an important role in regulating force development in the intact myocardium.
Insights
Protein kinase C (PKC) phosphorylation of cardiac troponin I (cTnI) at Ser43/45 depresses heart muscle force. This study shows that blocking these sites reduces force depression, highlighting their role in heart failure.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Biochemistry
Background:
- Protein kinase C (PKC) phosphorylation of cardiac myofilament proteins can impair actomyosin interaction.
- This PKC-mediated effect is implicated in the pathophysiology of heart failure.
- Specific phosphorylation sites on cardiac troponin I (cTnI), Ser43 and Ser45, are key to this depression.
Purpose of the Study:
- To investigate the role of specific PKC-dependent phosphorylation sites (Ser43 and Ser45) on cardiac troponin I (cTnI) in regulating cardiac muscle force.
- To compare the effects of PKC activation on cardiac muscle force in nontransgenic (NTG) and transgenic (TG) mice with altered cTnI phosphorylation sites.
Main Methods:
- Studied intact and detergent-extracted papillary muscles from NTG and TG mice expressing mutant cTnI (Ser43Ala, Ser45Ala).
- Administered phenylephrine (PE) to intact muscles and phorbol ester to detergent-extracted fibers.
- Utilized a PKC-specific inhibitor (chelerythrine) and measured cTnI and cardiac troponin T (cTnT) phosphorylation levels.
Main Results:
- Phenylephrine treatment caused a transient increase and subsequent 62% force reduction in NTG muscles, versus no transient increase and a 45% reduction in TG muscles.
- TG fibers showed reduced force depression compared to NTG fibers after phorbol ester treatment.
- PKC inhibition with chelerythrine blocked these force-regulating responses, and cTnI phosphorylation correlated with force changes, alongside decreased cTnT phosphorylation in TG fibers.
Conclusions:
- Specific PKC-mediated phosphorylation of Ser43 and Ser45 on cTnI is crucial for regulating force development in the intact myocardium.
- These findings provide direct evidence for the functional significance of cTnI phosphorylation in cardiac contractility.
- Targeting these specific phosphorylation sites may offer a therapeutic strategy for heart failure conditions characterized by impaired contractility.
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
09:32Methods for the Isolation, Culture, and Functional Characterization of Sinoatrial Node Myocytes from Adult Mice
Published on: October 23, 2016
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
cAMP-dependent Protein Kinase Pathways
G-Protein Gated Ion Channels
Sensory organs,...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...